Skip to main content

Table 1 Summary of the results of immunohistochemical reactions of the immune checkpoints on tumor cells in each of the six groups of the uterine mesenchymal neoplasms

From: Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors

  1. LM Leiomyoma, LMS Leiomyosarcoma, LMS—Rec Recurrent leiomyosarcoma, LMS—Met Metastatic leiomyosarcoma, ESS Endometrial stromal sarcoma, STUMP Smooth muscle tumor of uncertain malignant potential, SRC Sarcoma, Med Median, PD-L1 Programmed death-ligand 1, PD-1 Programmed cell death protein 1, CTLA-4 Cytotoxic T-lymphocyte-associated protein 4, IDO Indoleamine 2,3-dioxygenase, n + Number of positive cases, + Positive; Combined n + , at least one of the immune checkpoints is positive; Red, significant difference (p-value ≤ 0.05); Blue, borderline significant difference (0.05 < p-value < 0.1)